FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
PMA: P160039
·
Supplement: S011
·
Decision May 7, 2025
Classifications
1
FEI Numbers
3
Registration Numbers
3
Basic Information
- Device Name
- Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
- Trade Name
- remede System
- PMA Number
- P160039
- Supplement Number
- S011
- Device Class
- FDA Class 3
- Product Code
- PSR
- Generic Name
- Implanted phrenic nerve stimulator for central sleep apnea
- Medical Specialty
- Unknown
- Advisory Committee
- Anesthesiology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- May 7, 2025
- Date Received
- February 6, 2025
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
revised MR Conditional labeling of the remed?® System to remove the requirement to program the IPG to OFF mode prior to MRI scanning as the device automatically enters and remains in the Therapy Disabled (Magnet Mode) state during MRI exposure
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PSR | Implanted Phrenic Nerve Stimulator For Central Sleep Apnea | FDA class 3 | Unknown |